H40.6 Glaucoma secondary to drugs

Name of the Condition

• Glaucoma Secondary to Drugs

Summary

Glaucoma secondary to drugs is a condition characterized by increased intraocular pressure (IOP) or optic nerve damage resulting from the use of certain medications. This form of glaucoma may develop due to the pharmacological effects of drugs on the eye’s drainage structures or optic nerve, potentially leading to vision loss if not identified and managed promptly.

Causes

The condition arises when medications disrupt the eye’s normal fluid drainage or damage the optic nerve. Common mechanisms include drugs that alter the trabecular meshwork, reduce aqueous humor outflow, or directly affect optic nerve health. Examples include corticosteroids, certain antidepressants, and some anticholinergic agents, which can elevate IOP or cause optic nerve changes over time.

Risk Factors

• Prolonged use of corticosteroid medications (topical, inhaled, or systemic).
• Use of drugs known to affect intraocular pressure (e.g., some anticholinergics, antipsychotics).
• Pre-existing ocular conditions that increase susceptibility to drug-induced pressure changes.
• Genetic predisposition to steroid responsiveness.

Symptoms

• Elevated intraocular pressure (detected via tonometry).
• Vision changes, such as blurred vision or halos around lights.
• Eye discomfort or pain (less common).
• Progressive vision loss, particularly in peripheral fields, if optic nerve damage occurs.

Diagnosis

Diagnosis requires a thorough eye examination, including tonometry to measure IOP, gonioscopy to assess the drainage angle, and imaging (e.g., optical coherence tomography) to evaluate optic nerve damage. A detailed medication history is critical to correlate drug exposure with the onset of symptoms.

Treatment Options

Treatment focuses on discontinuing or adjusting the causative drug when possible, along with managing IOP. This may include topical or systemic medications to lower pressure, such as prostaglandin analogs, beta-blockers, or carbonic anhydrase inhibitors. In some cases, laser therapy or surgery may be necessary to improve aqueous outflow.

Prognosis and Follow-Up

Prognosis depends on the duration and severity of drug exposure, as well as the extent of optic nerve damage. Early intervention can prevent further vision loss, but irreversible damage may occur if treatment is delayed. Regular follow-up with an eye care provider is essential to monitor IOP and optic nerve health.

Complications

• Permanent vision loss due to optic nerve damage.
• Chronic elevated intraocular pressure requiring long-term management.
• Reduced quality of life from visual impairment.

Lifestyle & Prevention

• Avoid or limit use of medications known to increase IOP risk when possible.
• Inform healthcare providers of all medications, including over-the-counter drugs, to identify potential risks.
• Regular eye examinations for individuals on long-term drug therapy with known ocular side effects.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, eye pain, or persistent blurred vision, especially if you are taking medications known to affect intraocular pressure.

Tips for Medical Coders

When coding for glaucoma secondary to drugs, ensure documentation clearly links the condition to the specific medication(s) involved. Include details on the duration of drug use, any dose adjustments, and clinical findings (e.g., IOP measurements, optic nerve assessment) to support the diagnosis. Verify that the code H40.6 is appropriate and that the medical record supports the secondary nature of the glaucoma.